• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Cancer Immunotherapy in Urology, An Issue of Urologic Clinics

Cancer Immunotherapy in Urology, An Issue of Urologic Clinics

9780323754989
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
463,63 zł
394,09 zł Zniżka 69,54 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 394,09 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
The Guest Editors of this issue of Urologic Clinics of North America have put together a comprehensive collection of articles that provides the current knowledge on urologic cancer immunotherapy. Expert authors have contributed clinical review articles on the following topics:: Era of personalized vaccines for GU cancers; TCR and dendritic vaccine platforms for GU cancers; Neo-adjuvant platforms for GU cancer immunotherapy; Immune-editing in Cancer:: Role of tumor microenvironment and immune-suppressive pathways in localized and aggressive disease; Clinical integration of neo-adjuvant platforms for prostate cancer immunotherapy; Immunotherapy for muscle and non-muscle invasive bladder cancer:: BCG and beyond; Immunotherapy for metastatic bladder cancer; Immunotherapy options for metastatic castrate-resistant prostate cancer; Role of tissue infiltrating lymphocytes:: Understanding TCR; Therapeutic platforms for IPSC-derived CAR-T; Immune-suppression in prostate cancer:: Underlying causes and influence on response to immunotherapy; and Racial disparity in response to immunotherapy. Urologists will come away with the most current information they need to improve outcomes in the urologic cancer patient.
Szczegóły produktu
Elsevier
82434
9780323754989
9780323754989

Opis

Rok wydania
2020
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Waga (g)
450
Komentarze (0)